{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:16:56Z","timestamp":1791238616353,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61671276"],"award-info":[{"award-number":["61671276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11971269"],"award-info":[{"award-number":["11971269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejrad.2023.110747","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T12:30:11Z","timestamp":1676550611000},"page":"110747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Bronchial artery chemoembolization with drug-eluting beads versus bronchial artery infusion followed by polyvinyl alcohol particles embolization for advanced squamous cell lung cancer: A retrospective study"],"prefix":"10.1016","volume":"161","author":[{"given":"Guanghui","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-7153","authenticated-orcid":false,"given":"Wujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2023.110747_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, C.A","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2023.110747_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40425-018-0382-2","article-title":"The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of non-small-cell lung cancer (NSCLC)","volume":"6","author":"Brahmer","year":"2018","journal-title":"J. immunotherapy cancer"},{"key":"10.1016\/j.ejrad.2023.110747_b0015","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2023.110747_b0020","doi-asserted-by":"crossref","unstructured":"N.A. Rizvi, M.D. Hellmann, A. Snyder, P. Kvistborg, V. Makarov, J.J. Havel, et al. Cancer immunology. Mutational landscape determines sensitivity to PD\u20101 blockade in non\u2010small\u2010cell lung cancer, Science. 348(2015) 124\u2013128. doi: 10.1126\/science.aaa1348.","DOI":"10.1126\/science.aaa1348"},{"key":"10.1016\/j.ejrad.2023.110747_b0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41571-018-0138-4","article-title":"A banner year for immunotherapy and targeted therapy","volume":"16","author":"Carlisle","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2023.110747_b0030","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1200\/JCO.2012.42.6932","article-title":"Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial","volume":"30","author":"Ramlau","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2023.110747_b0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/CEJ.0000000000000594","article-title":"Progress in cancer mortality, incidence, and survival: a global overview","volume":"29","author":"Santucci","year":"2020","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ejrad.2023.110747_b0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejrad.2023.110747_b0045","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2023.110747_b0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jtho.2017.11.111","article-title":"Current and emergent therapy options for advanced squamous cell lung cancer","volume":"13","author":"Socinski","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejrad.2023.110747_b0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.lungcan.2012.04.006","article-title":"Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy","volume":"77","author":"Nakanishi","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejrad.2023.110747_b0060","first-page":"231","article-title":"Clinical outcomes of doxorubicin-eluting CalliSpheres\u00ae beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma, B.M.C","volume":"21","author":"Bi","year":"2021","journal-title":"Gastroenterol."},{"key":"10.1016\/j.ejrad.2023.110747_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5152\/dir.2017.16454","article-title":"Bronchial artery embolization in hemoptysis: a systematic review","volume":"23","author":"Panda","year":"2017","journal-title":"Diagn. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2023.110747_b0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00330-009-1591-3","article-title":"Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis","volume":"20","author":"Chun","year":"2010","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2023.110747_b0075","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1148\/radiol.13130046","article-title":"Bronchial artery embolization to control hemoptysis: comparison of N-butyl-2-cyanoacrylate and polyvinyl alcohol particles","volume":"269","author":"Woo","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2023.110747_b0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12967-021-02947-7","article-title":"Microspheres present comparable efficacy and safety profiles compared with polyvinyl alcohol for bronchial artery embolization treatment in hemoptysis patients","volume":"19","author":"Fu","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejrad.2023.110747_b0085","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jvir.2021.08.019","article-title":"Sintilimab plus Bronchial Arterial Infusion Chemotherapy\/Drug-Eluting Embolic Chemoembolization for Advanced Non-Small Cell Lung Cancer: A Preliminary Study of 10 Patients","volume":"32","author":"Li","year":"2021","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2023.110747_b0090","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.21037\/jtd-20-1603","article-title":"Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion","volume":"13","author":"Liu","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejrad.2023.110747_b0095","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.2147\/CMAR.S310115","article-title":"Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Relapsed\/Refractory Small Cell Lung Cancer Patients: Results from a Pilot Study","volume":"13","author":"Lin","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ejrad.2023.110747_b0100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/00325481.2020.1761711","article-title":"Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancer","volume":"132","author":"Yu","year":"2020","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.ejrad.2023.110747_b0105","article-title":"Efficacy and Safety of Drug-Eluting Bead Bronchial Arterial Chemoembolization Plus Anlotinib in Patients With Advanced Non-small-Cell Lung Cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejrad.2023.110747_b0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.lungcan.2020.06.010","article-title":"Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy","volume":"146","author":"Chen","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejrad.2023.110747_b0115","first-page":"2554","article-title":"Drug-eluting bead bronchial arterial chemoembolization vs. chemotherapy in treating advanced non-small cell lung cancer: comparison of treatment efficacy, safety and quality of life","volume":"25","author":"Liu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejrad.2023.110747_b0120","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jvir.2020.06.007","article-title":"Combination of Bronchial Arterial Infusion Chemotherapy plus Drug-Eluting Embolic Transarterial Chemoembolization for Treatment of Advanced Lung Cancer-A Retrospective Analysis of 23 Patients","volume":"31","author":"Zeng","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2023.110747_b0125","first-page":"1770","article-title":"The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer, Thorac","volume":"10","author":"Bie","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2023.110747_b0130","first-page":"2155","article-title":"Clinical effect of bronchial arterial infusion chemotherapy and CalliSpheres drug-eluting beads in patients with stage II-IV lung cancer: A prospective cohort study, Thorac","volume":"11","author":"Shang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2023.110747_b0135","first-page":"1827","article-title":"Trans-Arterial Chemoembolization Therapy for Refractory Advanced Non-Small Cell Lung Cancer with Spherical Embolic Material-A Single Case Report","volume":"42","author":"Kennoki","year":"2015","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.ejrad.2023.110747_b0140","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jvir.2017.06.003","article-title":"Transcatheter Arterial Chemoembolization with Spherical Embolic Agent in Patients with Pulmonary or Mediastinal Metastases from Breast Cancer","volume":"28","author":"Kennoki","year":"2017","journal-title":"J. Vasc. Interv. Radiol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X2300061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X2300061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:43:37Z","timestamp":1778539417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X2300061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":28,"alternative-id":["S0720048X2300061X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110747","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchial artery chemoembolization with drug-eluting beads versus bronchial artery infusion followed by polyvinyl alcohol particles embolization for advanced squamous cell lung cancer: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110747"}}